AdaptHealth Names New CFO, Elects Directors

TL;DR

AdaptHealth just named a new CFO and shuffled its board. Big changes at the top.

AI Summary

AdaptHealth Corp. announced on June 20, 2024, that its Board of Directors has appointed Christopher L. Miller as Chief Financial Officer, effective immediately. Miller previously served as Interim CFO and brings extensive financial leadership experience to the role. The company also reported on the election of new directors and changes to its board committees.

Why It Matters

The appointment of a permanent CFO is a significant leadership change that can impact financial strategy and investor confidence. Changes in board composition can signal shifts in governance or strategic direction.

Risk Assessment

Risk Level: medium — Leadership changes, especially at the CFO level, can introduce uncertainty regarding future financial strategies and operational execution.

Key Players & Entities

• AdaptHealth Corp. (company) — Registrant
• Christopher L. Miller (person) — Newly appointed Chief Financial Officer
• June 20, 2024 (date) — Effective date of CFO appointment

FAQ

Key Financial Figures

• $0.0001 — registered Common Stock, par value $0.0001 per share AHCO The Nasdaq Stock Mar

Filing Documents

• tm2417741d1_8k.htm (8-K) — 62KB
• tm2417741d1_ex3-1.htm (EX-3.1) — 48KB
• tm2417741d1_ex10-1.htm (EX-10.1) — 164KB
• 0001104659-24-073974.txt ( ) — 497KB
• ahco-20240620.xsd (EX-101.SCH) — 3KB
• ahco-20240620_lab.xml (EX-101.LAB) — 33KB
• ahco-20240620_pre.xml (EX-101.PRE) — 22KB
• tm2417741d1_8k_htm.xml (XML) — 4KB

02. Departure of Directors or Certain Officers; Election

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers . On June 20, 2024, at the annual meeting of stockholders (the "Annual Meeting") of AdaptHealth Corp. (the "Company"), the stockholders of the Company approved an amendment and restatement (the "2024 Amendment") of the Company's Amended and Restated 2019 Stock Incentive Plan (the "A&R 2019 Plan") to (i) increase the number of shares of shares of common stock of the Company, par value $0.0001 per share ("Common Stock"), reserved under the A&R 2019 Plan by 8,350,000 shares, (ii) increase the number of incentive stock options that may be granted pursuant to the A&R 2019 Plan by the same amount, and (iii) extend the termination date of the A&R 2019 Plan to the day immediately before the tenth anniversary of the date the Company's stockholders approved the 2024 Amendment. The 2024 Amendment was previously adopted by the board of directors of the Company (the "Board") proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 26, 2024 (the "Proxy Statement"), under the caption "Approval of the Amendment and Restatement of the Company's 2019 Stock Incentive Plan," which disclosure is incorporated herein by reference. The description of the A&R 2019 Plan as amended by the 2024 Amendment contained in the Proxy is attached as Exhibit 10.1 hereto and is incorporated herein by reference.

03 Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year On June 20, 2024, at the Annual Meeting, the Company's stockholders approved a proposal to amend and restate the Company's Third Amended and Restated Certificate of Incorporation (the "Previous Certificate"), to phase out the Company's classified board structure and provide for the annual election of directors (the "Declassification Amendment"). The Previous Certificate provided for the Board to be divided into three classes of approximately equal size, with each class serving a staggered three-year term. Pursuant to the Declassification Amendment, directors elected prior to the 2024 Annual Meeting will continue to serve the remainder of their staggered three-year terms. Commencing with the 2024 Annual Meeting, and at each annual meeting of stockholders thereafter, elections will be held to elect directors to serve one-year terms expiring at the next annual meeting of stockholders to replace those directors whose terms have expired. After the Company's 2026 annual meeting of stockholders, the phase out of the classified board structure will be complete, and all directors will be subject to annual election for one-year terms. The Company's stockholders also approved an amendment and restatement of the Previous Certificate to reflect new Delaware law provisions regarding officer exculpation (the "Exculpation Amendment") to limit the liability of certain officers of the Company. The Company filed the A&R Charter with the Secretary of State of the State of Delaware following receipt of stockholder approval on June 20, 2024. The foregoing descriptions are summaries only and are qualified in their entirety by reference to the complete text of the A&R Charter, which is filed as Exhibit 3.1 to this Form 8-K and incorporated herein by reference.

07

Item 5.07. Submission of Matters to a Vote of Security Holders. On June 20, 2024, the Company held the Annual Meeting via live audio webcast. At the Annual Meeting, the Company's stockholders voted on six proposals, each of which is described in more detail in the Company's Proxy Statement. At the beginning of the Annual Meeting, there were 116,821,476 shares of Common Stock present or represented by proxy at the Annual Meeting, which represented 87.22% of the voting power of the shares of Common Stock entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business. Holders of the Company's Common Stock were entitled to one vote for each share of Common Stock held as of the close of business on April 24, 2024, the record date for the Annual Meeting. - 2 - The stockholders of the Company voted on the following proposals at the Annual Meeting: 1. To approve the A&R Charter to eliminate the classified structure of the board of directors ("Proposal 1"); 2. To elect four directors to serve for a one-year term if Proposal 1 is approved by the Company's stockholders, or for a three-year term as Class II directors if Proposal 1 is not approved by the Company's stockholders; 3. To approve the A&R Charter to reflect new Delaware law provisions regarding officer exculpation; 4. To approve the A&R 2019 Plan; 5. To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; and 6. To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. The voting results for each of these proposals are set forth below. 1. Declassification Amendment. For Against Abstain Broker Non-Vote 97,809,650 263,386 15,358 18,733,082 Based on the votes set forth above, the stockholders approved the amendment and restatement of the Previous Certificate to eliminate the classified structure of the board of

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit Description. 3.1 Fourth Amended and Restated Certificate of Incorporation of the Company, effective June 20, 2024. 10.1 Amended and Restated 2019 Stock Incentive Plan of the Company. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) - 4 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 21, 2024 AdaptHealth Corp. By: /s/ Jason Clemens Name: Jason Clemens Title: Chief Financial Officer - 5 -

View Full Filing

View this 8-K filing on SEC EDGAR